Michael Arciprete
About Michael Arciprete
Michael Arciprete is a Senior Research Associate II at the Broad Institute of MIT and Harvard, specializing in metabolite profiling and clinical testing. He has a strong background in biochemistry and pharmacology, with experience in small molecule drug discovery and advanced mass spectrometry techniques.
Work at Broad Institute
Michael Arciprete has been employed at the Broad Institute of MIT and Harvard since 2021, serving as a Senior Research Associate II. In this role, he contributes to research initiatives in Cambridge, Massachusetts. His prior experience at the Broad Institute includes a position as Biochemist I from 2019 to 2021, where he focused on biochemical research and analysis.
Education and Expertise
Michael Arciprete holds a Master's degree in Pharmacology and Drug Development from Tufts University, which he completed from 2014 to 2016. He also earned a Bachelor's degree in Biochemistry and Molecular Biology from the University of Massachusetts, Amherst, from 2010 to 2014. His expertise includes metabolite profiling, clinical testing, high-resolution accurate mass spectrometry (HRAM-MS), and ultra-performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS).
Professional Background
Before his current role, Michael Arciprete worked in various positions within the life sciences sector. He was an Associate Scientist at Alnylam Pharmaceuticals from 2017 to 2019, progressing from Associate Scientist to Associate Scientist II. He also served as a Lab Technician III at Sanofi Genzyme from 2016 to 2017. Earlier in his career, he worked as a Building Manager's Assistant at Harvard University from 2010 to 2014.
Specialization in Drug Discovery
Michael Arciprete specializes in small molecule drug discovery, focusing on the development and testing of new pharmacological agents. His work involves utilizing advanced analytical techniques to support research and development efforts in the pharmaceutical industry.